1620 Investment Advisors »

United Therapeutics Corporation shares owned by 1620 Investment Advisors

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by 1620 Investment Advisors from 13F filings

Historical chart of 1620 Investment Advisors investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by 1620 Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by 1620 Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $161k 383 419.21
2025-06-30 $111k 386 287.35
2025-03-31 $120k 388 308.27
2024-12-31 $135k 383 352.84
2024-09-30 $144k 403 358.35
2024-06-30 $123k 386 318.55

More positions owned by 1620 Investment Advisors

Spdr Portfolio Intermediate Term Corporate Bond Etf Etf (SPIB)
Spdr Msci Eafe Strategicfactors Etf Etf (QEFA)
Ishares 7-10 Year Treasury Bond Etf Etf (IEF)
JPMorgan Chase & Co. (JPM)
Tri Contl Corp Cef (TY)
Spdr Portfolio Short Term Treasury Etf Etf (SPTS)
Freedom 100 Emerging Markets Etf Etf (FRDM)
Ishares 1-5 Year Investment Grade Corporate Bond Etf Etf (IGSB)
Apple (AAPL)
TJX Companies (TJX)
Schwab Us Tips Etf Etf (SCHP)
Microsoft Corporation (MSFT)
Janus Henderson Securitized Income Etf Etf (JSI)
Raytheon Technologies Corp (RTX)
Taiwan Semiconductor Mfg (TSM)

View all positions for 1620 Investment Advisors

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation